The article A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients, Chamberlain Mbah, Kim De Ruyck, Silke De Schrijver, Charlotte De Sutter, Kimberly Schiettecatte, Chris Monten, Leen Paelinck, Wilfried De Neve, Hubert Thierens, Catharine West, Gustavo Amorim, Olivier Thas & Liv Veldeman is now on Taylor & Francis Online. Acta Oncologica (published by Taylor and Francis) is a journal for the clinic
Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors
El propósito de este estudio internacional es tratar de predecir qué pacientes son más propensos a desarrollar efectos adversos tras la radioterapia
The first UK Interdisciplinary Breast Cancer Symposium will be held on 15th-16th January 2018 at Manchester Central Convention Centre. This two day conference will bring together the brightest minds in breast cancer management and research.
Petra Seibold ( Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany) gave an oral presentation at the 21st International Epidemiological Association (IEA) World Congress of Epidemiology (WCE2017) about: Quality of Life and patient-reported early adverse effects in prostate cancer patients treated with radiotherapy in the multi-centre observational REQUITE study.
Ms. Prof. Dr. Jenny Chang-Claude gave an oral presentation at the joint annual meeting of the DGEpi (Deutsche Gesellschaft für Epidemiologie), DGSMP (Deutschen Gesellschaft für Sozialmedizin und Prävention) und der DGMS (Deutsche Gesellschaft für Medizinische Soziologie) in Lübeck, Germany, on September 7th, 2017. http://www.gemeinsam-forschen.de/
The European Lung Cancer Congress is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, all working towards a shared goal: to advance science, disseminate education and improve the practice of lung cancer specialists worldwide.
For more information: website
ESTRO is a society focusing on interdisciplinarity and multidisciplinarity, giving radiation oncologists, medical physicists, radiobiologists, brachytherapists and radiation therapists (RTTs) the opportunity to engage with other oncology organisations with the collective aim of improving cancer treatment.
This conference will convey the theme ‘Innovation for Value and Access’. Click here for more information.
Annual REQUITE and Radiogenomics Consortium (RGC) meetings
ESMO is and continues to be a leading force of high-quality oncology education, a platform for immense international visibility for scientific research, and a proud contributor to continuous improvements in patient care.
For more information: website
ASTRO’S Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year.
Abstract Submission Site Opens: December 13, 2017
Abstract Submission Site Closes: February 14, 2018